Read More Medical Neratinib Included In NCCN Guidelines For Specific HER2-Negative Breast Cancers May 17, 2025
Read More Medical Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma May 12, 2025
Read More Medical Approved! With Just One Oral Dose Per Day, This Type Of Breast Cancer Patient Gets a New Drug May 23, 2025
